Main page
Education

Pharmaceutical Biotechnology

Data

Official data in SubjectManager for the following academic year: 2026-2027

Course director

Number of hours/semester

lectures: 28 hours

practices: 14 hours

seminars: 14 hours

total of: 56 hours

Subject data

  • Code of subject: OBA-115-T
  • 4 kredit
  • Biotechnology MSc
  • Basic modul
  • spring semester
Prerequisites:

OBA-128-T parallel

Course headcount limitations

min. 1 – max. 999

Topic

Pharmaceutical biotechnology

Lectures

  • 1. Intoduction - Pongrácz Judit Erzsébet
  • 2. Hybridoma in monoclonal antibody production - Pongrácz Judit Erzsébet
  • 3. Phage display 1 - Pongrácz Judit Erzsébet
  • 4. Phage display 2 - Pongrácz Judit Erzsébet
  • 5. Yeast display 1. - Pongrácz Judit Erzsébet
  • 6. Yeast display 2. - Pongrácz Judit Erzsébet
  • 7. Transgenic mice in human moclonal antibody I. - Pongrácz Judit Erzsébet
  • 8. Transgenic mice in human moclonal antibody II. - Pongrácz Judit Erzsébet
  • 9. Cell lines in antibody scaling up and production I. - Pongrácz Judit Erzsébet
  • 10. Cell lines in antibody scaling up and production II. - Pongrácz Judit Erzsébet
  • 11. Single B cell technologies and synthetic human antibody libraries - Pongrácz Judit Erzsébet
  • 12. Single B cell technologies and synthetic human antibody libraries - Pongrácz Judit Erzsébet
  • 13. Modern therapeutic antibody production – Nanobodies 1. - Pongrácz Judit Erzsébet
  • 14. Modern therapeutic antibody production – Nanobodies 1. - Pongrácz Judit Erzsébet
  • 15. Modern therapeutic antibody production – Nanobodies 2. - Pongrácz Judit Erzsébet
  • 16. Modern therapeutic antibody production – Nanobodies 2. - Pongrácz Judit Erzsébet
  • 17. Receptor production for CART cells 1. - Pongrácz Judit Erzsébet
  • 18. Receptor production for CART cells 2. - Pongrácz Judit Erzsébet
  • 19. Receptor production for CARNK cells 1. - Pongrácz Judit Erzsébet
  • 20. Receptor production for CARNK cells 2. - Pongrácz Judit Erzsébet
  • 21. Receptor production for CARM cells 1. - Pongrácz Judit Erzsébet
  • 22. Receptor production for CARM cells 2. - Pongrácz Judit Erzsébet
  • 23. Industrial challenges in protein drug production 1 - Pongrácz Judit Erzsébet
  • 24. Industrial challenges in protein drug production 2 - Pongrácz Judit Erzsébet
  • 25. Clinical trials - Pongrácz Judit Erzsébet
  • 26. Clinical trials - Pongrácz Judit Erzsébet
  • 27. Summary/questions - Pongrácz Judit Erzsébet
  • 28. Summary/questions - Pongrácz Judit Erzsébet

Practices

  • 1.

    Phage display

    - Papp Alexandra
  • 2. Phage display - Papp Alexandra
  • 3. Phage display - Papp Alexandra
  • 4. Phage dislplay - Papp Alexandra
  • 5. Phage display - Papp Alexandra
  • 6. Phage display - Papp Alexandra
  • 7. Phage display - Papp Alexandra
  • 8. Phage display - Papp Alexandra
  • 9.

    Phage display

    - Draskóczi Lilla Gréta
  • 10.

    Phage dislplay

    - Draskóczi Lilla Gréta
  • 11.

    Phage display

    - Draskóczi Lilla Gréta
  • 12.

    Phage display

    - Draskóczi Lilla Gréta
  • 13.

    Phage display

    - Draskóczi Lilla Gréta
  • 14.

    Phage display

    - Draskóczi Lilla Gréta

Seminars

  • 1. Phage display I. - Pongrácz Judit Erzsébet
  • 2. Phage display II. - Pongrácz Judit Erzsébet
  • 3. Phage display III. - Pongrácz Judit Erzsébet
  • 4. Phage dislplay IV - Pongrácz Judit Erzsébet
  • 5. Phage display V. - Pongrácz Judit Erzsébet
  • 6. Phage display VI. - Pongrácz Judit Erzsébet
  • 7. CAR receptor production - Pongrácz Judit Erzsébet
  • 8. CAR receptor production - Pongrácz Judit Erzsébet
  • 9. CAR receptor production - Pongrácz Judit Erzsébet
  • 10. CAR receptor production - Pongrácz Judit Erzsébet
  • 11. Clinical trials - Pongrácz Judit Erzsébet
  • 12. Clinical trials - Pongrácz Judit Erzsébet
  • 13. Industrial challenges in protein drug production - Pongrácz Judit Erzsébet
  • 14. Industrial challenges in protein drug production - Pongrácz Judit Erzsébet

Reading material

Obligatory literature

Literature developed by the Department

Lecture ppt

Notes

The written lecture notes are nearing completion. The modification focuses on novel methodologies employed in the pharmaceutical industry for the production of antibodies and CAR-T cells.

Recommended literature

Pharmaceutical biotechnology, Ed: Gary Walsh, Wiley

Conditions for acceptance of the semester

Attendance to 75% of lectures and practices

Mid-term exams

Written test

Making up for missed classes

None

Exam topics/questions

meetstreet, Teams, Moodle

Examiners

  • Pongrácz Judit Erzsébet

Instructor / tutor of practices and seminars

  • Draskóczi Lilla Gréta
  • Papp Alexandra
  • Pongrácz Judit Erzsébet
Rólunk